NAD+

NAD+, or nicotinamide adenine dinucleotide, is a molecule found throughout the body that plays an important role in cellular energy production, metabolism, DNA repair, and cellular signaling. Because NAD+ is involved in processes related to energy and cellular function, it has become an area of interest in longevity, metabolic health, and cognitive performance. However, understanding the biological role of NAD+ is different from proving that supplemental NAD+ will improve energy, cognition, or aging in every patient. At Fountain, NAD+ is considered as one potential tool within a broader clinical plan, not as a universal treatment for fatigue or aging.

Patients often ask about NAD+ because they are experiencing low energy, reduced mental clarity, slower recovery, or changes in performance, or because they are interested in supporting long-term health. Those symptoms can have many causes. Poor sleep, nutritional deficiencies, hormonal changes, medications, mental health conditions, metabolic issues, and other medical problems can produce similar complaints. That is why Fountain starts with the clinical picture rather than assuming that NAD+ is the answer. Your provider considers your symptoms, health history, medications, goals, and other relevant factors before determining whether NAD+ belongs in your care plan.

There is no established response timeline, and not everyone experiences a noticeable effect. Some patients seek NAD+ therapy hoping to improve energy, mental clarity, or recovery, but current human evidence does not establish a predictable improvement in these outcomes or a specific timeframe in which benefits should occur. Human studies of NAD-related therapies have demonstrated biological effects, but clinical outcomes have been inconsistent, and direct evidence for injectable NAD+ remains limited. Rather than promising a particular sensation or result, Fountain looks at whether treatment produces a meaningful change in the reason it was prescribed.

Side effects can vary depending on the formulation, dose, and route of administration. Reported reactions with injectable NAD+ have included nausea, vomiting, fatigue, chills or shaking, flushing, cramping, and discomfort during administration. Because injectable NAD+ may be compounded, product quality and sourcing matter. FDA has reported adverse events associated with compounded NAD+ injections containing excessive endotoxins and has specifically warned compounders about using ingredients that are not appropriate for sterile injectable products. Your clinician should review potential risks and provide instructions specific to the product and protocol you are prescribed.

We start with why you are considering it. If the concern is fatigue, brain fog, recovery, or declining performance, the first step is understanding whether another medical, hormonal, nutritional, sleep-related, psychiatric, or metabolic factor may better explain the symptoms. If NAD+ is incorporated into your plan, we define what improvement should look like and follow the relevant symptoms or functional goals over time. Depending on the reason for treatment, that might include energy, cognition, sleep, recovery, or day-to-day functioning. If there is no meaningful benefit, the treatment should be reconsidered rather than continued automatically.

No. Compounded NAD+ is not an FDA-approved finished drug product. FDA does not review compounded medications for safety, effectiveness, or manufacturing quality before they are dispensed in the same way it reviews an FDA-approved medication. That does not mean every compounded medication is inappropriate, but it makes prescribing oversight, pharmacy selection, sourcing, sterility, and patient education particularly important. Fountain considers compounded therapies individually and discusses their potential benefits, limitations, and uncertainties before treatment.